157 related articles for article (PubMed ID: 22449703)
41. Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Zhang J; Zhan P; Wu J; Li Z; Jiang Y; Ge W; Pannecouque C; De Clercq E; Liu X
Bioorg Med Chem; 2011 Jul; 19(14):4366-76. PubMed ID: 21683601
[TBL] [Abstract][Full Text] [Related]
42. Design, synthesis and biological evaluation of cycloalkyl arylpyrimidines (CAPYs) as HIV-1 NNRTIs.
Gu SX; Yang SQ; He QQ; Ma XD; Chen FE; Dai HF; Clercq ED; Balzarini J; Pannecouque C
Bioorg Med Chem; 2011 Dec; 19(23):7093-9. PubMed ID: 22037050
[TBL] [Abstract][Full Text] [Related]
43. A peptide with HIV-1 reverse transcriptase inhibitory activity from the medicinal mushroom Russula paludosa.
Wang J; Wang HX; Ng TB
Peptides; 2007 Mar; 28(3):560-5. PubMed ID: 17113195
[TBL] [Abstract][Full Text] [Related]
44. Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies.
Zhan P; Liu X; Li Z; Fang Z; Li Z; Wang D; Pannecouque C; Clercq ED
Bioorg Med Chem; 2009 Aug; 17(16):5920-7. PubMed ID: 19620009
[TBL] [Abstract][Full Text] [Related]
45. Wikstroelide M potently inhibits HIV replication by targeting reverse transcriptase and integrase nuclear translocation.
Zhang X; Huang SZ; Gu WG; Yang LM; Chen H; Zheng CB; Zhao YX; Wan DC; Zheng YT
Chin J Nat Med; 2014 Mar; 12(3):186-93. PubMed ID: 24702804
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
Roth T; Morningstar ML; Boyer PL; Hughes SH; Buckheit RW; Michejda CJ
J Med Chem; 1997 Dec; 40(26):4199-207. PubMed ID: 9435891
[TBL] [Abstract][Full Text] [Related]
47. Non-nucleoside HIV reverse transcriptase inhibitors, Part 6[1]: synthesis and anti-HIV activity of novel 2-[(arylcarbonylmethyl)thio]-6-arylthio DABO analogues.
Sun GF; Kuang YY; Chen FE; De Clercq E; Balzarini J; Pannecouque C
Arch Pharm (Weinheim); 2005 Oct; 338(10):457-61. PubMed ID: 16211654
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.
Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
Bioorg Med Chem; 2007 May; 15(9):3134-42. PubMed ID: 17349793
[TBL] [Abstract][Full Text] [Related]
49. Revealing interaction mode between HIV-1 reverse transcriptase and diaryltriazine analog inhibitor.
Li Z; Han J; Chen HF
Chem Biol Drug Des; 2008 Nov; 72(5):350-9. PubMed ID: 19012571
[TBL] [Abstract][Full Text] [Related]
50. A potent anti-HIV polyphenol from Salvia yunnanensis.
Zhang ZF; Chen HS; Peng ZG; Li ZR; Jiang JD
J Asian Nat Prod Res; 2008; 10(3-4):273-7. PubMed ID: 18335344
[TBL] [Abstract][Full Text] [Related]
51. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
[TBL] [Abstract][Full Text] [Related]
52. Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays.
Chen W; Zhan P; Rai D; De Clercq E; Pannecouque C; Balzarini J; Zhou Z; Liu H; Liu X
Bioorg Med Chem; 2014 Mar; 22(6):1863-72. PubMed ID: 24581546
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and biological evaluation of 2',3'-didehydro-2',3'- dideoxy-5-fluorocytidine (D4FC) analogues: discovery of carbocyclic nucleoside triphosphates with potent inhibitory activity against HIV-1 reverse transcriptase.
Shi J; McAtee JJ; Schlueter Wirtz S; Tharnish P; Juodawlkis A; Liotta DC; Schinazi RF
J Med Chem; 1999 Mar; 42(5):859-67. PubMed ID: 10072683
[TBL] [Abstract][Full Text] [Related]
54. An unusual "senseless" 2',5'-oligoribonucleotide with potent anti-HIV activity.
Aboul-Fadl T; Agrawal VK; Buckheit RW; Broom AD
Nucleosides Nucleotides Nucleic Acids; 2004; 23(3):545-54. PubMed ID: 15113022
[TBL] [Abstract][Full Text] [Related]
55. New pyridinone derivatives as potent HIV-1 nonnucleoside reverse transcriptase inhibitors.
Le Van K; Cauvin C; de Walque S; Georges B; Boland S; Martinelli V; Demonté D; Durant F; Hevesi L; Van Lint C
J Med Chem; 2009 Jun; 52(12):3636-43. PubMed ID: 19469474
[TBL] [Abstract][Full Text] [Related]
56. Enantioselective inhibition of reverse transcriptase (RT) of HIV-1 by non-racemic indole-based trifluoropropanoates developed by asymmetric catalysis using recyclable organocatalysts.
Han X; Ouyang W; Liu B; Wang W; Tien P; Wu S; Zhou HB
Org Biomol Chem; 2013 Dec; 11(48):8463-75. PubMed ID: 24202207
[TBL] [Abstract][Full Text] [Related]
57. Uvaria angolensis as a promising source of inhibitors of HIV-1 RT-associated RNA-dependent DNA polymerase and RNase H functions.
Ngoutane Mfopa A; Corona A; Eloh K; Tramontano E; Frau A; Boyom FF; Caboni P; Tocco G
Nat Prod Res; 2018 Mar; 32(6):640-647. PubMed ID: 28540745
[TBL] [Abstract][Full Text] [Related]
58. Development of a series of 3-hydroxyquinolin-2(1H)-ones as selective inhibitors of HIV-1 reverse transcriptase associated RNase H activity.
Suchaud V; Bailly F; Lion C; Tramontano E; Esposito F; Corona A; Christ F; Debyser Z; Cotelle P
Bioorg Med Chem Lett; 2012 Jun; 22(12):3988-92. PubMed ID: 22607675
[TBL] [Abstract][Full Text] [Related]
59. QSAR for anti-HIV activity of HEPT derivatives.
Bazoui H; Zahouily M; Boulajaaj S; Sebti S; Zakarya D
SAR QSAR Environ Res; 2002 Oct; 13(6):567-77. PubMed ID: 12479372
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and biological evaluation of (±)-benzhydrol derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Ma XD; Zhang X; Yang SQ; Dai HF; Yang LM; Gu SX; Zheng YT; He QQ; Chen FE
Bioorg Med Chem; 2011 Aug; 19(16):4704-9. PubMed ID: 21788138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
